Last deal

$200M

Amount

Post-IPO Equity

Stage

26.06.2024

Date

19

all rounds

$865.4M

Total amount

General

About Company
Recursion integrates technology to improve patient lives and industrialize drug discovery.

Industry

Sector :

Subsector :

Also Known As

Recursion Pharmaceuticals, Inc., Recursion

founded date

05.11.2013

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Recursion Pharmaceuticals Inc leverages technological innovations to decode complex biology and build the next-generation biopharmaceutical company. The Recursion Operating System generates one of the world's largest and fastest-growing proprietary biological and chemical datasets, which is explored using the Recursion Map, a suite of custom software, algorithms, and machine learning tools. The company's culture values diversity in expertise, gender, race, disciplines, experience, and perspectives, which is critical to achieving its audacious goals. Recursion is headquartered in Salt Lake City.
Contacts